EXAS vs GBCI · rev $2.76B vs P/E 23, rev $55.0M
EXACT Sciences Corporation (EXAS) versus Glacier Bancorp Inc (GBCI) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Glacier Bancorp Inc (GBCI) is a banks - regional company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported GBCI revenue for 2026-06-30 was $55.0M. Net income was $180.0M. GBCI currently screens at market cap $6.27B and trailing P/E 22.5.
EXAS currently screens at market cap $20.03B. GBCI currently screens at market cap $6.27B and trailing P/E 22.5.
Not investment advice. Open the EXAS and GBCI stock pages for the full models.
Not investment advice.